ATE293983T1 - Verwendung von n-acetyl-d-glucosamin bei der herstellung eines arzneimittels zur unterdrückung der nebenwirkungen von strahlentherapie und chemotherapie - Google Patents
Verwendung von n-acetyl-d-glucosamin bei der herstellung eines arzneimittels zur unterdrückung der nebenwirkungen von strahlentherapie und chemotherapieInfo
- Publication number
- ATE293983T1 ATE293983T1 AT02703474T AT02703474T ATE293983T1 AT E293983 T1 ATE293983 T1 AT E293983T1 AT 02703474 T AT02703474 T AT 02703474T AT 02703474 T AT02703474 T AT 02703474T AT E293983 T1 ATE293983 T1 AT E293983T1
- Authority
- AT
- Austria
- Prior art keywords
- glucosamine
- acetyl
- chemotherapy
- suppressing
- production
- Prior art date
Links
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 title abstract 3
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 title abstract 3
- 230000000694 effects Effects 0.000 title abstract 3
- 229950006780 n-acetylglucosamine Drugs 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000002512 chemotherapy Methods 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 238000001959 radiotherapy Methods 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- 238000002560 therapeutic procedure Methods 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN01104882A CN1131036C (zh) | 2001-02-28 | 2001-02-28 | N－乙酰－d－氨基葡萄糖在制备抑制放化疗副反应药物中的应用 |
| PCT/CN2002/000119 WO2002067946A1 (fr) | 2001-02-28 | 2002-02-28 | Utilisation de la n-acetyl-d-glucosamine dans la preparation de compositions pharmaceutiques utilisees dans la suppression des effets secondaires causes par la radiotherapie et la chimiotherapie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE293983T1 true ATE293983T1 (de) | 2005-05-15 |
Family
ID=4654071
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02703474T ATE293983T1 (de) | 2001-02-28 | 2002-02-28 | Verwendung von n-acetyl-d-glucosamin bei der herstellung eines arzneimittels zur unterdrückung der nebenwirkungen von strahlentherapie und chemotherapie |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7037904B2 (de) |
| EP (1) | EP1374873B8 (de) |
| CN (1) | CN1131036C (de) |
| AT (1) | ATE293983T1 (de) |
| DE (1) | DE60203895T2 (de) |
| WO (1) | WO2002067946A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1210038C (zh) * | 2003-03-27 | 2005-07-13 | 中国人民解放军第三军医大学 | N－乙酰氨基葡萄糖在制备用于治疗毒物和药物中毒致脏器损伤的药物中的应用 |
| JP2007506645A (ja) * | 2003-09-17 | 2007-03-22 | 中国人民解放▲軍▼第三▲軍▼医大学 | 抗腫瘍および抗転移のための製剤の製造におけるｎ−アセチル−ｄ−グルコサミンの使用 |
| JP2009503061A (ja) * | 2005-08-03 | 2009-01-29 | ナショナル キャンサー センター | トランスグルタミナーゼ抑制剤として有用なグルコサミンまたはその誘導体 |
| CN104267185B (zh) * | 2014-09-12 | 2016-05-18 | 范飞舟 | 检测肿瘤的试剂盒及其专用识别n-乙酰氨基葡萄糖的物质 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4216208A (en) * | 1978-07-31 | 1980-08-05 | Proter S.P.A. | N-Acyl derivatives of glucosamines having antitumor chemotherapeutic activity |
| US4710493A (en) * | 1984-08-14 | 1987-12-01 | Albert Landsberger | Therapeutic agent for the use in cancer treatment |
| CA1340994C (en) * | 1989-09-21 | 2000-05-16 | Rudolf Edgar Dr. Falk | Treatment of conditions and disease |
| US5229374A (en) * | 1992-01-28 | 1993-07-20 | Burton Albert F | Method for treatment of lower gastrointestinal tract disorders |
| CA2132427A1 (en) * | 1992-03-19 | 1993-09-30 | Albert F. Burton | Method and composition for suppresion of side effects of anti-inflammatory drugs |
| CN1067246C (zh) | 1996-12-27 | 2001-06-20 | 中国人民解放军第三军医大学 | N－乙酰－d－氨基葡萄糖在制备治疗皮肤癣菌的药物中的应用 |
| CN1095366C (zh) | 1996-12-27 | 2002-12-04 | 中国人民解放军第三军医大学 | N－乙酰－d－氨基葡萄糖在制备治疗肠道疾病药物中的应用 |
| CN1067245C (zh) | 1996-12-27 | 2001-06-20 | 中国人民解放军第三军医大学 | N－乙酰－d－氨基葡萄糖在制备治疗呼吸道疾病的药物中的应用 |
-
2001
- 2001-02-28 CN CN01104882A patent/CN1131036C/zh not_active Expired - Fee Related
-
2002
- 2002-02-28 EP EP02703474A patent/EP1374873B8/de not_active Expired - Lifetime
- 2002-02-28 DE DE60203895T patent/DE60203895T2/de not_active Expired - Lifetime
- 2002-02-28 WO PCT/CN2002/000119 patent/WO2002067946A1/zh not_active Ceased
- 2002-02-28 AT AT02703474T patent/ATE293983T1/de not_active IP Right Cessation
- 2002-02-28 US US10/469,327 patent/US7037904B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1374873B1 (de) | 2005-04-27 |
| US20040077596A1 (en) | 2004-04-22 |
| CN1131036C (zh) | 2003-12-17 |
| US7037904B2 (en) | 2006-05-02 |
| EP1374873B8 (de) | 2005-06-29 |
| EP1374873A4 (de) | 2004-08-11 |
| EP1374873A1 (de) | 2004-01-02 |
| WO2002067946A1 (fr) | 2002-09-06 |
| CN1372929A (zh) | 2002-10-09 |
| DE60203895T2 (de) | 2005-09-29 |
| HK1061530A1 (en) | 2004-09-24 |
| DE60203895D1 (de) | 2005-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200505483A (en) | New medicament compositions based on anticholinergically-effective compounds and β-mimetics | |
| IL267381A (en) | A pharmaceutical preparation containing dextromethorphan and quinidine for the treatment of nervous disorders | |
| MX2023001997A (es) | Compuestos biciclicos, composiciones y usos de los mismos. | |
| IL138723A0 (en) | Antitumor agent | |
| MY147643A (en) | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder | |
| DE60135647D1 (de) | Zusammensetzungen zur normalisierung des zirkadianen rythmus | |
| TNSN05180A1 (en) | Liquid pharmaceutical formulations of palonosetron | |
| DK1365808T3 (da) | Sammensætninger til antitumorbehandling indeholdende ecteinascidin 743 | |
| DE60209721D1 (de) | Oxazolo- und furopyrimidine und deren verwendung als medikamente gegen tumore | |
| EP1503748A4 (de) | Arzneimittel zur linderung durch taxan induzierte neurotoxizität | |
| ATE372774T1 (de) | Medikament zur verabreichung von amifostin und verwandten wirkstoffen | |
| IL165086A (en) | Pyridyl cyanoguanidines, pharmaceutical compositions comprising them and uses thereof for the preparation of medicaments | |
| ATE293983T1 (de) | Verwendung von n-acetyl-d-glucosamin bei der herstellung eines arzneimittels zur unterdrückung der nebenwirkungen von strahlentherapie und chemotherapie | |
| AU2003245989A8 (en) | Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases | |
| DE60216292D1 (de) | Calciumtrifluoracetat mit zytotoxischer wirkung | |
| WO2002076393A3 (en) | Antiagionecic, antitumor, chemopreventative agents | |
| TW200501958A (en) | A therapeutic agent for treating a behavioral disorder | |
| PL375354A1 (en) | Use of treosulfan and derivatives thereof for treating multiple sclerosis | |
| DE60309926D1 (de) | Steroid-verbindungen mit anti-tumoraler wirkung | |
| WO1999003509A3 (de) | Pharmazeutische mittel enthaltend perfluoralkylgruppenhaltige trijodaromaten und ihre verwendung in der tumortherapie und interventionellen radiologie | |
| MXPA05003633A (es) | 2"-oxo-voruscharina y derivados de la misma. | |
| BG105763A (en) | Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors | |
| AU2003298203A1 (en) | Medicaments containing substituted 2,5-diaminomethyl-1h-pyrroles |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1374873 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |